全文获取类型
收费全文 | 4626篇 |
免费 | 494篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 117篇 |
妇产科学 | 119篇 |
基础医学 | 717篇 |
口腔科学 | 53篇 |
临床医学 | 533篇 |
内科学 | 780篇 |
皮肤病学 | 46篇 |
神经病学 | 435篇 |
特种医学 | 157篇 |
外科学 | 689篇 |
综合类 | 107篇 |
一般理论 | 2篇 |
预防医学 | 472篇 |
眼科学 | 60篇 |
药学 | 427篇 |
中国医学 | 3篇 |
肿瘤学 | 367篇 |
出版年
2021年 | 57篇 |
2020年 | 40篇 |
2019年 | 60篇 |
2018年 | 73篇 |
2017年 | 60篇 |
2016年 | 68篇 |
2015年 | 83篇 |
2014年 | 115篇 |
2013年 | 157篇 |
2012年 | 226篇 |
2011年 | 194篇 |
2010年 | 122篇 |
2009年 | 91篇 |
2008年 | 164篇 |
2007年 | 194篇 |
2006年 | 184篇 |
2005年 | 176篇 |
2004年 | 169篇 |
2003年 | 161篇 |
2002年 | 148篇 |
2001年 | 177篇 |
2000年 | 169篇 |
1999年 | 122篇 |
1998年 | 71篇 |
1997年 | 67篇 |
1996年 | 83篇 |
1995年 | 55篇 |
1994年 | 51篇 |
1993年 | 64篇 |
1992年 | 142篇 |
1991年 | 123篇 |
1990年 | 111篇 |
1989年 | 130篇 |
1988年 | 112篇 |
1987年 | 92篇 |
1986年 | 68篇 |
1985年 | 79篇 |
1984年 | 67篇 |
1983年 | 45篇 |
1982年 | 35篇 |
1981年 | 30篇 |
1980年 | 36篇 |
1979年 | 47篇 |
1978年 | 51篇 |
1977年 | 41篇 |
1975年 | 42篇 |
1974年 | 40篇 |
1973年 | 36篇 |
1971年 | 38篇 |
1966年 | 28篇 |
排序方式: 共有5129条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
The association of circulating endotoxin with the development of the adult respiratory distress syndrome 总被引:6,自引:0,他引:6
P E Parsons G S Worthen E E Moore R M Tate P M Henson 《The American review of respiratory disease》1989,140(2):294-301
Despite extensive investigation, the pathogenesis of the adult respiratory distress syndrome (ARDS) remains uncertain. As yet, there is no clear explanation of why some patients at risk for ARDS develop the syndrome, whereas others do not. Neutrophils and complement fragments have been implicated in the acute lung injury, but it is clear from published data that evidence of complement activation alone predicts neither the development nor the severity of ARDS. We investigated whether the combination of endotoxin, a leukocyte-priming agent, and complement fragments, leukocyte-stimulating agents, was associated with the development of ARDS. Ninety-eight patients were identified as being either at risk for the development of ARDS or having ARDS, and serial blood samples were obtained. There was no correlation between C5 fragments and the development of ARDS. C3 fragment levels were increased in 89% of the patients with ARDS, but they were also increased in 62% of patients at risk. Endotoxin was detected in 74% of the plasma samples obtained from patients at risk who subsequent developed ARDS and in 64% of the plasma samples obtained from the patients with ARDS. In contrast, only 22% of the plasma samples obtained from the patients at risk who did not develop ARDS had measurable endotoxin. We suggest that the combination of endotoxin and complement fragments may be one mechanism involved in the development of ARDS. 相似文献
6.
7.
Breuer J.; Moniz C.; Baldwin D.; Parsons V. 《Nephrology, dialysis, transplantation》1987,2(5):347-350
The effect of oral magnesium carbonate aluminium hydroxide onserum ionised calcium, total calcium, aluminium and magnesium,was assessed in 31 patients with chronic renal failure, duringand after one haemodialysis. The behaviour of ionised calcium and total calcium was the samein both groups. Each showed a slight fall during dialysis, whichwas not significant. Serum total calcium was 0.20.3 mmol/l(0.81.2 mg/dl) greater throughout the period of dialysisin the group taking aluminium hydroxide. Serum magnesium andaluminium were both lower in the group treated with magnesiumcarbonate. In the group taking magnesium carbonate, serum magnesium concentrationsfell markedly during dialysis, but otherwise were maintainedwithin the reference range by the use of a magnesium-free dialysate.These results show the effectiveness of magnesium carbonateoral phosphate-binding agents and zero magnesium dialysate inreducing serum aluminium without affecting the behaviour ofserum calcium fractions during dialysis. 相似文献
8.
J Halbrecht C A Carlstedt J R Parsons D A Grande 《Clinical orthopaedics and related research》1990,(259):245-255
Growth hormone has chondrogenic affects on normal as well as on damaged articular cartilage. In this study, the influence of growth hormone is investigated on early degenerative changes in the articular cartilage in 72 New Zealand white rabbits. Cartilage lesions were created in femoral condyles using an immobilization model. Cartilage damage was assessed using biochemical, histologic, and biomechanical criteria. Growth hormone had no influence on prevention of immobilization abnormalities but had a significant affect on healing of established lesions. 相似文献
9.
C. L. Parsons 《World journal of urology》1994,12(1):38-42
Summary Investigations into the antibacterial defense mechanisms of the urinary tract revealed an important function for cell surface glycosaminoglycans (GAG), that of a generalized antiadherent activity. This activity was found to prevent bacterial, protein, and ionic adherence to the cell membrane. A model was developed to explain mechanically the activity of sulfated polysaccharides at the bladder surface. The model predicted injurious effects of quaternary amines and also that the mucus would be the so-called blood-urine barrier. It also led to the hypothesis that exogenous polysaccharides may be important in treating bladder disease such as infection and interstitial cystitis. For the first clinical test of these concepts, a polysaccharide was employed in several double-blind studies and was shown to ameliorate significantly the symptoms of interstitial cystitis. These discoveries suggest new methods to manipulate the microenvironment between the transitional cell surface and the urine, leading to novel therapies in regulating disease of the genitourinary tract. They also stress the importance of understanding the mechanisms by which GAGs exert their effect in the urinary tract and how they are produced, maintained, and even inactivated (e.g., by urinary substances such as protamine).Supported by the Medical Research Service of the Veterans Administration, Urological Research and Education Foundation, and by National Institutes of Health grant R01DK39239. 相似文献
10.
Darren S Parsons David A Reaveley Darrell V Pavitt Madhukar Misra Edwina A Brown 《Nephrology, dialysis, transplantation》2003,18(9):1848-1853
BACKGROUND: Studies have reported an increase in median Lipoprotein (Lp) (a) in patients with high molecular weight (HMW) apolipoprotein (apo) (a) isoforms and renal impairment. Some studies identify Lp (a) levels as a risk factor for vascular disease in renal failure whilst others have demonstrated an association with apo (a) isoform type and vascular disease. METHODS: A total of 239 patients at end-stage renal failure (ESRF) were studied prior to the initiation of dialysis. Blood was taken for Lp (a) levels and apo (a) isoforms. Clinical vascular disease (CVD) was assessed on the basis of clinical history and Rose questionnaire. The control group for Lp (a) levels consisted of 228 healthy volunteers. RESULTS: Despite a higher median Lp (a) level in those with HMW isoforms, 30% of patients had Lp (a) levels <10 mg/dl. Overall, 49% patients were identified as having CVD. Diabetes, smoking history and Lp (a) levels were significantly associated with CVD in logistic regression analysis, although when patients with low molecular weight (LMW) and HMW isoforms were analysed separately, Lp (a) levels were not significantly associated with CVD in those with LMW isoforms. The rates of CVD in those with HMW isoform and low Lp (a) levels were significantly lower than those with HMW isoforms and elevated Lp (a) levels, 34 vs 57% (P < 0.01). CONCLUSIONS: Although median Lp (a) levels in those patients at ESRF with HMW isoforms are higher than controls, in a third of such patients Lp (a) levels remain relatively low. These patients have lower rates of CVD than those with high levels of Lp (a). 相似文献